Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia

Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia

Background: In addition to reducing plasma lipids, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors may produce numerous nonlipid-related pleiotropic effects. The purpose of this trial was to determine the efficacy of PCSK9 inhibitors alone in patients with isolated hypercholesterole...

Full description

Bibliographic Details
Main Authors: Marcin Basiak, Marcin Hachula, Michal Kosowski, Boguslaw Okopien
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Clinical Medicine
Subjects:
PCSK9 inhibitor
factor VII
hypercholesterolemia
plasminogen activator inhibitor-1
von Willebrand factor
hemostasis
Online Access:https://www.mdpi.com/2077-0383/11/9/2542

Internet

https://www.mdpi.com/2077-0383/11/9/2542

Similar Items